Veterinary Medicines

Biocan Novel Respi, nosies lašai, liofilizatas ir tirpiklis suspensijai ruošti šunims

Authorised
  • Canine parainfluenza virus, strain CPiV-2-Bio 15, Live
  • Bordetella bronchiseptica, strain MSLB 3096, Live
Download as PDF

Product identification

Medicine name:
Biocan Novel Respi, nosies lašai, liofilizatas ir tirpiklis suspensijai ruošti šunims
Active substance:
  • Canine parainfluenza virus, strain CPiV-2-Bio 15, Live
  • Bordetella bronchiseptica, strain MSLB 3096, Live
Target species:
  • Dog
Route of administration:
  • Nasal use

Product details

Active substance and strength:
  • Canine parainfluenza virus, strain CPiV-2-Bio 15, Live
    3.50
    log10 50% tissue culture infectious dose
    /
    1.00
    Dose
  • Bordetella bronchiseptica, strain MSLB 3096, Live
    8.00
    log10 colony forming unit(s)
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate and solvent for oral suspension
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AF01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Lithuania

Additional information

Entitlement type:
  • Parallel Trade Approval
Marketing authorisation date:
Responsible authority:
  • State Food And Veterinary Service
Authorisation number:
  • ĮV-64
Parallel trade in reference of:
Parallel trade of:
Source wholesaler:
  • Bertas Nams SIA
Destination wholesaler:
  • Vetfarmas UAB